Journals / Arşiv Kaynak Tarama Dergisi / 2022 / Cilt: 31 - Sayı: 1

An Overview of NLRP3 Inflammasome Activation and Regulation Mechanisms

NLRP3 İnflamazom Aktivasyon ve Düzenleme Mekanizmalarına Genel Bir Bakış

Pages
52–59
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review presents the current understanding of the mechanisms of NLRP3 inflammasome activation, as well as recent advances in the non-canonical and alternative inflammasome pathways.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The innate immune system is vital in host defense against pathogens entering the body.
📊
Key Findings & Data:The NLRP3 (NACHT-, LRR- and Pyrin Domain Containing 3) inflammasome, a component of the innate immune system, is a multimeric protein complex.
💡
Conclusion & Impact:In this review presents the current understanding of the mechanisms of NLRP3 inflammasome activation, as well as recent advances in the non-canonical and alternative inflammasome pathways.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The innate immune system is vital in host defense against pathogens entering the body. The NLRP3 (NACHT-, LRR- and Pyrin Domain Containing 3) inflammasome, a component of the innate immune system, is a multimeric protein complex. Inflammasome activation is a process that starts and improves differently from classical inflammatory responses. In order to induce inflammasome activation, there must be a danger signal such as DAMP (Damage-Associated Molecular Pattern) or PAMP (Pathogen-Associated Molecular Pattern) detected. In response to these stimuli, caspase-1 is activated. This in turn leads to cleavage and maturation of potent pro-inflammatory cytokines, IL-1β (interleukin-1β) and IL-18 (interleukin-18) by mature caspase-1. Thus, inflammatory responses mediated by IL-1β and IL-18 are activated. Although NLPR3 activation is an important immune response, its overactivation can cause inflammatory disorders and cell death. For this reason, regulation and inhibition of the NLRP3 inflammasome may be a promising treatment approach for these autoinflammatory diseases. In this review presents the current understanding of the mechanisms of NLRP3 inflammasome activation, as well as recent advances in the non-canonical and alternative inflammasome pathways.

Özet

Doğal bağışıklık sistemi, vücuda giren patojenlere karşı konakçı savunmasında hayati önem taşır. Doğal bağışıklık sisteminin bir bileşeni olan NLRP3 (NACHT-, LRR- ve pirin alanı içeren 3) inflamazom, multimerik bir protein kompleksidir. İnflamazom aktivasyonu klasik enflamatuvar cevaplardan farklı olarak başlayan ve gelişen bir süreçtir. NLRP3 inflamazom aktivasyonunun oluşması için DAMP'ler (Hasarlanma ile ilişkili moleküler modeller) ve PAMP'ler (Patojenle ilişkili moleküler modeller) gibi çeşitli tehlike sinyallerinin olması gerekir. Bu uyaranlara yanıt olarak, kaspaz-1 aktive olur. Aktif kaspaz-1 de, IL-1β (interlökin-1β) ve IL-18 (interlökin-18) sitokinlerinin öncül halde bulunan formlarını proteolitik olarak böler ve aktif hale getirir. Böylece IL-1β ve IL-18 aracılı enflamatuvar yanıtlar aktive olur. NLPR3 aktivasyonu önemli bir bağışıklık cevabı olmasına rağmen aşırı aktivasyonu enflamatuvar hastalıklara ve hücre ölümüne neden olabilmektedir. Bu nedenden dolayı, NLRP3 inflamazomunun regülasyonu ve inhibisyonu otoenflamatuvar hastalıklar için umut verici bir tedavi yaklaşımı olabilir. Bu derlemede, NLRP3 inflamazom aktivasyon mekanizmaları hakkındaki mevcut anlayışın yanı sıra standart olmayan ve alternatif inflamazom yolaklarındaki son gelişmeler sunulmuştur.

🔖

Cite This Article

Polat, S., Şaker, D. (2022). An Overview of NLRP3 Inflammasome Activation and Regulation Mechanisms. Arşiv Kaynak Tarama Dergisi, Cilt: 31 - Sayı: 1, 52–59. https://ajindex.com/articles/449043

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Kesikli SA, Güç D. Steril İnflamasyon ve İnflamazom. ANKEM Derg. 2011;25:102-9
  2. Sharma D, Kanneganti TD. The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation. J. Cell Biol. 2016;213:617–29
  3. Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int. J. Mol. Sci. 2019;20:3328
  4. Schroder K, Tschopp J. The Inflammasomes. Cell. 2010;140:821–32
  5. Shao B, Xu Z, Han B, Su D, Liu C. NLRP3 inflammasome and its inhibitors: a review. Frontiers in Pharmacolog. 2015;6:262
  6. Trdizin. Available from: https://app.trdizin.gov.tr/dokumangoruntule?ext=pdf&path=CrnWZGRsXTjRjLjWxD978OSUAL2jXitizhVYmCxNvH4Z8Ahs_kDHkpOxOpWgszYwDyLz tUwSuCHva_2PxJac6LjQwtnm8RiZLCI2oA_RET6abSR9cp62ynnLp3sfPyY70W8607s7mQZM810EOcuowow_Bq5symY zpbJlJABjs7JZpI13HG1vGn4Li84WOfSzdJrsxZxRjlCPJ9sZtOkSBOw_3uNLnlGCpPJDhfrBbIk=&contentType=applicati on/pdf. Accessed: 12 October 2021
  7. He Y, Hara H, Nunez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 2016;41:1012– 21
  8. Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E. Targeting the NLRP3 inflammasome in inflammatory diseases. Nature Reviews. 2018;17:588-606
  9. Şahin C, Arıcıoğlu F. Depresyon ve Sitokin Hipotezinde Yeni Bir Boyut: ‘NLRP3 İnflamazomu’. MÜSBED. 2013;3:65-8
  10. Fernandes-Alnemri T, Wu J, Yu JW, Datta P, Miller B, Jankowski W, Rosenberg S, Zhang J, Alnemri ES. The pyroptosome: A supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ. 2007;14:1590–604
  11. Arıöz Bİ. Melatonin´in Mikroglial Hücrelerde İnflamazom Aktivasyonuna Etkisi (Yüksek Lisans Tezi). İzmir. Dokuz Eylül Üniversitesi. 2017
  12. Kim N, Kim H, Lee J, Jo S, Won H, Lee G et al. Juglone Suppresses LPS-induced Inflammatory Responses and NLRP3 Activation in Macrophages. Molecules. 2020;25;3104
  13. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D et al. Cutting Edge: NF-kB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression. J. Immunol. 2009;183:787-91
  14. Gurung P, Anand PK, Malireddi RKS, Walle LV, Opdenbosch NV, Dillon CP et al. FADD and Caspase-8 Mediate Priming and Activation of the Canonical and Noncanonical Nlrp3 Inflammasomes. J. Immunol. 2014;192:1835–46
  15. Allam R, Lawlor KE, Yu ECW, Mildenhall AL, Moujalled DM, Lewis RS et al. Mitochondrial apoptosis is dispensab